The present invention provides a cancer vaccine composition fortransdermal administration for cellular immunity induction,comprising (i) a WT1 peptide and/or a modified WT1 peptide; and(ii) a pharmacologically acceptable acid as a first cellularimmunity induction promoter, or a pharmacologically acceptablesalt thereof.